Calithera Biosciences Inc (CALA)
0.0250
-0.01
(-37.38%)
USD |
OTCM |
Apr 18, 15:03
Calithera Biosciences Accounts Receivable (Quarterly)
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2022 | 0.127M |
| December 31, 2021 | |
| September 30, 2021 | 0.012M |
| June 30, 2021 | 0.012M |
| March 31, 2021 | 1.028M |
| December 31, 2020 | 1.541M |
| September 30, 2020 | 0.466M |
| June 30, 2020 | 0.923M |
| March 31, 2020 | 0.976M |
| December 31, 2019 | 0.482M |
| September 30, 2019 | 1.712M |
| Date | Value |
|---|---|
| June 30, 2019 | 1.74M |
| March 31, 2019 | 2.513M |
| December 31, 2018 | 1.997M |
| September 30, 2018 | 1.809M |
| June 30, 2018 | 2.511M |
| March 31, 2018 | 1.824M |
| December 31, 2017 | 1.142M |
| September 30, 2017 | 2.177M |
| June 30, 2017 | 2.303M |
| March 31, 2017 | 13.55M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
0.012M
Minimum
Jun 2021
1.74M
Maximum
Jun 2019
0.8199M
Average
0.923M
Median
Jun 2020
Accounts Receivable (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 0.759M |
| Palatin Technologies Inc | 2.346M |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Ampio Pharmaceuticals Inc | -- |